Pavmed

[HCR20]

US based medical biotech company. Seems to be very innovative with products just coming online.

Could be a good time to get in.

[Joshuatree]

Thanks, got any links?

[HCR20]

https://ecan.org/2020/02/18/fda-calls-new-screening-test-using-dna-to-detect-esophageal-cancer-a-breakthrough-device/

https://seekingalpha.com/amp/article/4389889-pavmeds-pavm-ceo-lishan-aklog-on-q3-2020-results-earnings-call-transcript

Here's something to start with. Speculative play and be wary of exchange rate risk, but they seem to have a number of highly innovative products that are just coming to market.

[HCR20]

https://stm.sciencemag.org/content/10/424/eaao5848.full

[HCR20]

Pavmed hiring for reimbursements today. A good sign.

[HCR20]

TA looking good. Looking forward to next announcement that should include medicare reimbursements. 3 of 3 analysts calling buy with YE value of $5. Volatile stock and higher risk play but let's roll the dice. All going well, plan is to continue to accumulate pending announcements.

[HCR20]

Business update on Feb 22.

[HCR20]

Recent article.
PAVmed's Esophageal Diagnostic Tools Should Create Strong Shareholder Value https://seekingalpha.com/article/4404684-pavmeds-esophageal-diagnostic-tools-should-create-strong-shareholder-value

You can also watch their esoguard product and advert on you tube.

Stock up 18% today. So far I'm up around 60%. As noted, expected $5 by year end. High risk/reward stock tho. Looking forward to the update later this month.

[HCR20]

PAVM up around 30% today. Too far too fast, and will need to pull back, but this might mean leaked info about upcoming announcements have reached instos. Anyway, I was hoping for $5 by year end, but we might get there sooner. Let's see.

[HCR20]

New PR today. Not enough to be driving the share price but its something...

https://ir.pavmed.com/news-events/press-releases/detail/139/first-u-s-patient-undergoes-successful-minimally-invasive

[HCR20]

Conference call on Mon, 8.30am EST.

[HCR20]

Quite a bit of news this week.

Share price rocked to >$5 early in the week meaning that this stock has more than doubled in the last few months.

Conference call on Mon morn signaled intent to spin off Lucid. Later that day management indicated intent to do another cash raise further diluting investors. No revenue reported at this time.

Further dilution resulted in a pull back of around 17% but new analyses indicate revised price consensus for 2021 of around $9 an increase from $5. This would represent an approx 4× gain since the start of the year. My plan is to hold for a couple of years.

[HCR20]

Conference call transcript.

I'm buying more..

https://seekingalpha.com/article/4408007-pavmeds-pavm-ceo-lishan-aklog-on-business-update-and-preliminary-q4-2020-results-earnings

[HCR20]

Down bigly. Topping up.

[HCR20]

Down bigly. Topping up.

Topped up in low 3's. Let's see what happens. Next Flo FDA approval could be on the cards.

[HCR20]

Topped up in low 3's. Let's see what happens. Next Flo FDA approval could be on the cards.

Now up to just below $5. Recent analysts see it around $8. Will see how Lucid spin off goes.

[Cricketfan]

What do you guys use to buy US shares? I'm interested in Pavmed but Hatch don't have it (and won't get it). Same with Rocketlab when it lists.

[HCR20]

What do you guys use to buy US shares? I'm interested in Pavmed but Hatch don't have it (and won't get it). Same with Rocketlab when it lists.

I buy through Jarden brokerage.

PAVM is too small for Hatch/Sharsies etc.

[HCR20]

Something is up.. PAVM share price increased by around 23% yesterday. Could be buyout or new product or whale buying big... Anyone waiting on the sidelines mind want to pause before we understand what is driving the SP appreciation.

[HCR20]

Okay, so share price has had a lot of volatility lately. Word is there are $5 option calls expiring today and that the MM are manipulating the stock down so that the options expire worthless. If SP bounces back next week then this thesis will be confirmed. Wait and see.

[HCR20]

Share price still going strong. Good acquisition today.

Some DD...

https://docs.google.com/document/u/1/d/e/2PACX-1vTd8Nv1VLHLry90vhPRUt8DuUmgur1KD3VThm_rc41IFDAtu-G_Fk83vneqg8o1s9c1cFT_BKiHgWl-/pub?urp=gmail_link&gxid=8203366

[HCR20]

Stanley announced as vice chair on board. SP lifted 20% this week.

[HCR20]

Triple bagger now. Seems pretty crazy since they are still pretty much pre revenue. Anyone who is not in at this stage, I wouldn't recommend getting in at these levels. I wouldn't be surprised to see a pullback to $5 at some stage.

[HCR20]

PAVM now on Sharsies if anyone is interested. Tread carefully as very risky and pre revenue. Announced IPO for Lucid diagnostics so will probably fly tomorrow.